Fairman Group’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3
Closed -$566 340
2026
Q1
$566 Hold
3
﹤0.01% 302
2025
Q4
$596 Hold
3
﹤0.01% 310
2025
Q3
$609 Hold
3
﹤0.01% 253
2025
Q2
$528 Hold
3
﹤0.01% 236
2025
Q1
$379 Hold
3
﹤0.01% 236
2024
Q4
$379 Hold
3
﹤0.01% 323
2024
Q3
$499 Hold
3
﹤0.01% 357
2024
Q2
$399 Hold
3
﹤0.01% 358
2024
Q1
$315 Hold
3
﹤0.01% 362
2023
Q4
$227 Buy
+3
New +$190 ﹤0.01% 371

Other funds holding THC

Fairman Group's THC Position: Q2 2026 in Review

Fairman Group sold out of Tenet Healthcare (THC) in Q2 2026, closing a stake of 3 shares — an estimated $566 sold.

Fairman Group first reported a position in THC in Q4 2023 and held it in 10 quarters. The position peaked at $609 in Q3 2025. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Fairman Group reported no remaining Tenet Healthcare position as of Q2 2026 after selling out during the quarter.
  • Fairman Group sold 3 Tenet Healthcare shares in Q2 2026, an estimated $566.
  • Fairman Group first reported a position in Tenet Healthcare in Q4 2023 and held it in 10 quarters.
  • Fairman Group's Tenet Healthcare position peaked at $609 in Q3 2025.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Fairman Group's 13F filing for Q2 2026, filed 4 Aug 2026.